References
- American Society of Breast Surgeons. Consensus guideline on genetic testing for hereditary breast cancer. Available online at: breastsurgeons.org/docs/statements/Consensus-Guideline-on-Genetic-Testing-for-Hereditary-Breast-Cancer.pdf. Last accessed August 5, 2020.
- Brewer H, Jones M, Schoemaker M, Ashworth A, Swerdlow A. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat. 2017;165(1):193‐200.
- Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001;344(4):276‐285.
- Sun H, Zou J, Chen L, et al. Triple negative breast cancer and its association with obesity. Mol Clin Oncol. 2017;7(6):935‐942. doi: 10.3892/mco.2017.1429.
- Shelton C, Dixon C. Genetics update at The Outer Banks Hospital. Quality study, 2019 (updated also in 2020).
- NCCN guidelines. Available online at: nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf. Last accessed August 5, 2020.
- Gail model for breast cancer risk. mdcalc.com/gail-model-breast-cancer-risk. Last accessed August 5, 2020.
- Tyrer J, Duffy S, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111‐1130.
- Shelton C, Smith T, Boehmer L, Weldon C, Guenther W, Trosman J, Ruiz A. Population genetic screening for hereditary breast and ovarian cancer in at‐risk patients: a novel testing and prevention model for community hospitals reveals high rates rurally. Paper presented at: ASCO Virtual Annual Meeting; May 29, 2020; Chicago, IL.
- Duffy S, Morrish O, Allgood P, Black R, Gillan M, Willsher P, et al. Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer. Eur J Cancer. 2018;48‐56.
- Ikonopedia. IBIS (International Breast Cancer Intervention Study) online Tyrer‐Cuzick model breast cancer risk evaluation tool. Version 8. Available online at: ibis.ikonopedia.com. Last accessed August 5, 2020.
- Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647‐2650.
- Complementary and alternative medicine. Available online at: cancer.gov/about‐cancer/treatment/cam. Last accessed August 5, 2020.
- Bowen C, Hearne RH, Shelton CH. IM getting a seat at the oncology table: adding integrative medicine to the tumor board discussion prospectively. Paper presented at: Society for Integrative Oncology; 15th International Conference October 27‐29, 2018; Scottsdale, AZ.
- Breast cancer risk and prevention. Available online at: cancer.org/cancer/breast‐cancer/risk‐and‐prevention.html. Last accessed August 5, 2020.
- ASCO 2019: impact of diet and exercise on breast cancer risk. Available online at: patientpower.info/breast-cancer/living-with-breast-cancer/asco-2019-impact-of-diet-and-exercise-on-breast-cancer-risk. Last accessed August 5, 2020.
- Breast Cancer Weight Loss Study (BWEL). Available online at: clinicaltrials.gov/ct2/show/NCT02750826. Last accessed August 5, 2020.
- Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health‐related quality of life: results from the American Cancer Society's SCS‐II. J Clin Oncol. 2008;26(13):2198‐2204. doi: 10.1200/JCO.2007.14.6217.
- Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to promote healthy living in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2363‐2373. doi: 10.1200/JCO.2008.21.
- Commission on Cancer, Cancer Quality Improvement Program. CoC data from CQIP report for compilation of all NCDB hospitals references a target of 90 percent use of HT in women under 70 years of age with HR + breast cancer. Available online at: ncdbapp.facs.org/NCDB.CQIPDS.V2/resources/public/CQIP_2018_Slide_Directory.pdf. Last accessed August 5, 2020.